Search

everythinglearnresearchcommunity

for

Search:↓

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

EGFR inhibitors can cause skin issues, and managing these is important for treatment success.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

CRISPR gene editing reduces harmful molecules in cells from Emery–Dreifuss Muscular Dystrophy patients.

The use of Diane-35 and its generics significantly decreased in the Netherlands.

MSC-derived EVs show promise for therapy, but production and understanding need improvement.

EV-based therapies are advancing but need to overcome challenges for full potential.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

Diane and Androcur 10 improved acne and seborrhea in most women, and hirsutism and alopecia in about half.

The study concludes that mutations in the AEBP1 gene can cause a form of Ehlers-Danlos syndrome and should be considered in diagnosis.

Combining topical delgocitinib with a 308-nm excimer laser can effectively treat severe alopecia areata and vitiligo.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Deep eutectic solvents are eco-friendly and effective for extracting useful pharmaceutical compounds.

Erenumab significantly reduced migraine days or severity in most patients after 3 months.

Two women had skin reactions from a hair loss treatment and got better after stopping use.

Extracellular vesicles can help treat skin issues like wounds, hair loss, aging, and inflammation.

IL10_ApoEVs improve skin healing and reduce scarring.

Amivantamab can cause severe skin eruptions and scarring, requiring drug discontinuation and early treatment.

Beer yeast vesicles may improve hair follicle health.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

PRIDE complex side effects from EGFR inhibitors can be managed without stopping treatment.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Wedelolactone may help treat chronic diseases due to its strong antioxidant properties.

Extracellular vesicles show promise for medical use but face challenges in standardization and safety.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

3D cell spheroids can help reduce scars by delivering therapeutic vesicles.